Teva to Present at the Bear Stearns 10th Annual London Healthcare Conference
Posted on: Wednesday, 12 March 2008, 06:00 CDT
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Bear Stearns 10th Annual Healthcare Conference in London. Dan Suesskind, Chief Financial Officer, and Dr. Gerard Van Odijk, President and CEO of Teva Europe, will present on Thursday, March 13, 2008.
What:
Teva Presentation at the Bear Stearns 10th Annual Healthcare Conference in London
Who:
Dan Suesskind, Chief Financial Officer
Dr. Gerard Van Odijk, President and CEO, Teva Europe
When:
Thursday, March 13, 2008 1:15 p.m. GMT
Where:
www.tevapharm.com or http://cc.talkpoint.com/BEAR002/031308a_sc/?entity=teva
How:
Live over the Internet -- Simply log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
About Teva
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.
Source: Business Wire
Related Articles
- Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
- Teva Pharmaceuticals USA Responds to FDA Findings on Budeprion XL 300 Mg
- Teva Pharmaceutical Industries, Ltd. (TEVA) President, CEO, CFO and Chairman of the Board to Ring the NASDAQ Stock Market Opening Bell
- Teva Pharmaceuticals USA Issues Statement on the ``Preserve Access to Affordable Generics Act''
- Teva Pharmaceutical Industries Ltd. And Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two Biopharmaceuticals, Based on Protalix's Recombinant Plant Cell Expression Technology
- Cephalon, Inc. Announces Agreement With Teva Pharmaceutical Industries Ltd. Regarding Settlement of PROVIGIL(R) Patent Litigation
- Agvar Chemicals Sues Barr Laboratories, Teva Pharmaceuticals USA in Connection With Barr's Generic Alternative to Allegra(R)
- Teva Pharmaceutical 2Q Profit Rises
- Teva Pharmaceutical 2Q Profit Increases
- Teva Pharmaceutical to Buy Ivax for $7.4B
User Comments (0)

RSS Feeds